
#514 Hotcakes: Oral Semaglutide, Fish Oil in ESRD, IV Iron During Infection, New US Dietary Guidelines, & Anticoagulation after Ablation in AFib
The Curbsiders Internal Medicine Podcast
00:00
Oral semaglutide shows substantial weight loss
Matthew Watto and Rahul Ganatra review a phase 3 trial showing ~13.6% weight loss versus 2.2% placebo and GI side effects.
Play episode from 01:19
Transcript


